drugset / Trial / NCT00605410

Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness

NCT00605410

RandomizedCrossoverTriple-blindDiagnostic

Summary

Certain lung disease medications can influence diagnostic tests and research investigations. This study will investigate how long ipratropium bromide must be withheld before a methacholine challenge test can be conducted. This information will be useful for validating current guidelines.

Timeline

Start
2008-01
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ipratropium Small molecule 40 ug Inhaled

Indications